Is Now the Ideal Time ETH? Analysts See Path to $5K
Analysts outline a potential breakout path for Ethereum toward $5,000, but warn that macro headwinds and on-chain dyn...
This intro outlines the cheapest index funds for retirement accounts in 2024 and explains how to balance cost with performance and risk.
24,050 articlesAnalysts outline a potential breakout path for Ethereum toward $5,000, but warn that macro headwinds and on-chain dyn...
Amazon briefly overtook SpaceX as the world's fifth-largest company by market cap. Here are three reasons that leader...
Amazon delivered a blockbuster Q1 2026, but a record capex plan raises questions about the stock’s two-year path. Her...
Analysts issue refreshed Tuesday notes on a slate of large-cap names, signaling where investors may push for upside a...
Micron’s shares fell about 12% at the open amid a broad market rout. Yet analysts see a longer-term memory shortage d...
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Sarah Jessica Parker’s journey from a large, struggling family to a $200 million fortune highlights how grit and ambi...
A data-driven model now sees roughly 36% upside for Qualcomm stock within a year, even after a choppy period around i...
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
A sudden stock pullback creates a rare entry point for patient investors. The company combines non-discretionary serv...
Microsoft rides a renewed wave of optimism as cloud and AI demand fuels a bullish price target consensus. Analysts in...
The Supreme Court ruling blocks state-law cancer claims against Bayer tied to Roundup, a decision that reshapes litig...